Cocrystal Pharma, Inc.
롱

$COCP Short Articles Published Drowned out by FACTS PPS Rises

450
03-06-2020, 3.5 Million Share Institutional Buy-In tells only a snippet of the overall story with this dream stock.

sec.report/Document/0001104659-20-029961/a20-11569_2sc13g.htm

To get the real grasp of what we have here, look to my previous post and take in this analogy as deeply as possible:

In the Coronavirus Market: COCP is to Treatment what IBIO is to Vaccines or what OPK is to Testing.

COCP has completed all the financing and funding needed with two public offerings recently and are now aggressively pursing the development of Novel Anitiviral Compounds for treatment of any Corona infections including COVID-19

They have exclusive patent rights to the treatment and are in the process of advancing it quickly through a preclinical trial program.

Shorts will continue to write articles to downplay these facts as much as possible because the stock has a HUGE short position

면책사항

해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.